Skip to content

Company information lookup

MAYNE PHARMA GROUP LIMITED (MYX)

Develops, manufactures and markets branded and generic pharmaceutical products globally

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
MYX 0.755 -1.31% 0.755 0.765 0.770 0.772 0.755 288,239

MAYNE PHARMA GROUP LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code MYX
Securities
Official Listing Date 29 June, 2007
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.maynepharma.com
Registered Office Address Level 14, 474 Flinders Street, MELBOURNE, VIC, AUSTRALIA, 3000
Head Office Telephone (03) 8614 7777
Head Office Fax (03) 9614 7022
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
YARRA FALLS, 452 JOHNSTON STREET, ABBOTSFORD, VIC, AUSTRALIA, 3067
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Roger Corbett, AO (Chairman)
Mr Scott Richards (CEO)
Prof. Bruce G Robinson (Director)
The Hon Ron Best (Non Exec. Director)
Mr Phil Hodges (Non Exec. Director)
Mr Bruce Mathieson (Non Exec. Director)
Mr Ian Scholes (Non Exec. Director)
Mr Mark Cansdale (CFO)
Ms Lisa Pendlebury (Investor Relations)
Company Secretary Mr Mark Cansdale
Principal Activities Develops, manufactures and markets branded and generic pharmaceutical products globally

MAYNE PHARMA GROUP LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
18/11/2014 asterix Mayne Pharma announces US Paragraph IV Challenge 2 PDF
30/10/2014   Appendix 3B 9 PDF
27/10/2014   Notice of Annual General Meeting/Proxy Form 10 PDF
07/10/2014   Change of Director's Interest Notice 3 PDF
30/09/2014   Initial Director's Interest Notice 2 PDF
10/09/2014   Appendix 3B 9 PDF
05/09/2014   Change in substantial holding from BTT 16 PDF
05/09/2014   Change in substantial holding from WBC 15 PDF
27/08/2014   2014 Corporate Governance Statement 15 PDF
27/08/2014   2014 Full Year Results Investor Presentation 20 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
21 Nov 2014 0.755 -1.31% 0.772 0.755 288,239
20 Nov 2014 0.765 1.32% 0.775 0.755 1,696,045
19 Nov 2014 0.755 0% 0.770 0.755 162,814
18 Nov 2014 0.755 -3.82% 0.775 0.750 662,981
17 Nov 2014 0.785 4.67% 0.785 0.755 460,878

* Volume of shares shown represents only those shares traded on ASX.

MAYNE PHARMA GROUP LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security MYX. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security MYX

Warrants & Structured Products

No warrants & Structured Products are available over the security MYX